Eli Lilly Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
1. LLY to report earnings on May 1, expected at $3.46 per share. 2. Projected quarterly revenue is $12.72 billion, up from $8.77 billion. 3. Phase 3 results for diabetes drug orforglipron were recently reported. 4. HSBC downgraded LLY from Buy to Reduce, cutting price target to $700. 5. Wells Fargo increased price target to $1,100, maintaining Overweight rating.